Ignite Creation Date:
2024-05-06 @ 8:27 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06393517
Status:
COMPLETED
Last Update Posted:
2024-07-03
First Post:
2024-04-26
Brief Title:
A Study to Learn How Different Forms of the Study Medicine Called PF-06954522 Are Taken up Into the Blood in Healthy Adults
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A PHASE 1 OPEN-LABEL RANDOMIZED 5-PERIOD 6-SEQUENCE CROSSOVER STUDY TO COMPARE THE SINGLE-DOSE PHARMACOKINETICS OF IMMEDIATE-RELEASE AND MODIFIED-RELEASE FORMULATIONS OF PF-06954522 ADMINISTERED ORALLY TO HEALTHY ADULT PARTICIPANTS
Status:
COMPLETED
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to compare three finished products of PF-06954522 in terms of the uptake into the blood stream
This study is seeking participants who are
- Healthy male or female participants aged 18 years or older
All participants in this study will receive PF-06954522 once by mouth The participants may receive different tablets by mouth for PF-06954522
The study will compare experiences of people receiving three different products of PF-06954522 This will help understand how much PF-06954522 is taken up into the blood for each product given
Participants will take part into the study for about 77 days During this time participants will have to stay onsite for 21 days There will be one follow up by telephone study visit
This study is seeking participants who are
- Healthy male or female participants aged 18 years or older
All participants in this study will receive PF-06954522 once by mouth The participants may receive different tablets by mouth for PF-06954522
The study will compare experiences of people receiving three different products of PF-06954522 This will help understand how much PF-06954522 is taken up into the blood for each product given
Participants will take part into the study for about 77 days During this time participants will have to stay onsite for 21 days There will be one follow up by telephone study visit
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None